Long-term benefit of triheptanoin treatment in patients with GLUT1 deficiency

This study shows that long-term treatment with triheptanoin in patients with GLUT1 deficiency can lead to sustained clinical benefits, particularly by reducing movement disorders. It suggests that triheptanoin is a valuable alternative to ketogenic diets, with good tolerability.